Richard Rosenblum

Amedia Networks, Inc. designs, develops, and markets Ethernet-based solutions that can be deployed with optical fibers or copper wires to offer voice, video and data broadband services. The company products enable service providers to offer voice, video and high-speed internet access, or 'triple-play' services, to their subscribers. The company was founded in July 1994 and is headquartered in Eatontown, NJ.

HG Partners, Inc. provides commercial and residential installation and maintenance (HVAC) services in the heating, ventilation, and air conditioning industry. The company was founded in January 2006 and is headquartered in Pearland, TX.

Harborview Capital Management LLC (Harborview) is an independent hedge fund manager headquartered in New York City. The firm was founded by David “Dave” Stefansky in 2004. Harborview manages the assets of high-net-worth clients.

The Company is currently an inactive company seeking merger and business operations opportunities. On 27-Oct-2006, the Company ceased operations, and discontinued all business activities.

Celsia Technologies, Inc. provides thermal management products and technology for the personal computer, consumer electronics, and light emitting diode lighting and display industries. It focuses on research, development, and commercialization of next-generation cooling solutions. The company operates in the United States and Taiwan. Celsia Technologies was founded on December 23, 1999 and is headquartered in Miami, FL.

vFinance, Inc. provides financial services. It offers institutional brokerage and investment banking services to the professional traders, hedge funds, and other institutional clients. The company was founded by Leonard Jay Sokolow and Timothy Mahoney in February 1992 and is headquartered in Boca Raton, FL.

Alliqua, Inc. is a biomedical products company focused on the development and manufacturing of proprietary technologies in the fields of drug delivery, advanced wound care and liver health preservation. It intends to develop active ingredient and transdermal drug delivery products, primarily utilizing the proprietary hydrogel technology platform manufactured by its subsidiary AquaMed Technologies, Inc. The firm develops HepaMate, an extracorporeal cell-based bioartificial liver system designed to combine blood detoxification with liver cell therapy to provide whole liver function in patients with the most severe forms of liver failure. Its HepaMate is comprised of a blood plasma separation cartridge, a hollow-fiber bioreactor filled with proprietary porcine liver cells, a charcoal column, an oxygenator, circuit tubing and a plasma reservoir. The company was founded on October 21, 1997 and is headquartered in New York, NY. It changed its name from HepaLife Technologies, Inc. in January 2011.